Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial

被引:68
|
作者
Cladder-Micus, Mira B. [1 ,2 ,3 ]
Speckens, Anne E. M. [3 ]
Vrijsen, Janna N. [2 ,4 ]
Donders, A. Rogier T. [5 ]
Becker, Eni S. [1 ]
Spijker, Jan [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands
[2] Pro Persona Mental Hlth Care, Depress Expertise Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, POB 9101,Internal Postal Code 966, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Dept Psychiat, Donders Inst Brain Cognit & Behav, Med Ctr, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands
关键词
depressive disorder; mindfulness; quality of life; randomized controlled trial; treatment-resistant depression; BEHAVIORAL ANALYSIS SYSTEM; MAUDSLEY STAGING METHOD; PSYCHOMETRIC PROPERTIES; GROUP VERSION; PSYCHOTHERAPY; EFFICACY; RELAPSE; QUESTIONNAIRE; REPLICATION; POPULATION;
D O I
10.1002/da.22788
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
BackgroundChronic and treatment-resistant depressions pose serious problems in mental health care. Mindfulness-based cognitive therapy (MBCT) is an effective treatment for remitted and currently depressed patients. It is, however, unknown whether MBCT is effective for chronic, treatment-resistant depressed patients. MethodA pragmatic, multicenter, randomized-controlled trial was conducted comparing treatment-as-usual (TAU) with MBCT + TAU in 106 chronically depressed outpatients who previously received pharmacotherapy (4weeks) and psychological treatment (10 sessions). ResultsBased on the intention-to-treat (ITT) analysis, participants in the MBCT + TAU condition did not have significantly fewer depressive symptoms than those in the TAU condition (-3.23 [-6.99 to 0.54], d=0.35, P=0.09) at posttreatment. However, compared to TAU, the MBCT + TAU group reported significantly higher remission rates ((2)(2)=4.25, =0.22, P=0.04), lower levels of rumination (-3.85 [-7.55 to -0.15], d=0.39, P=0.04), a higher quality of life (4.42 [0.03-8.81], d=0.42, P=0.048), more mindfulness skills (11.25 [6.09-16.40], d=0.73, P<0.001), and more self-compassion (2.91 [1.17-4.65], d=0.64, P=0.001). The percentage of non-completers in the MBCT + TAU condition was relatively high (n=12, 24.5%). Per-protocol analyses revealed that those who completed MBCT + TAU had significantly fewer depressive symptoms at posttreatment compared to participants receiving TAU (-4.24 [-8.38 to -0.11], d=0.45, P=0.04). ConclusionAlthough the ITT analysis did not reveal a significant reduction in depressive symptoms of MBCT + TAU over TAU, MBCT + TAU seems to have beneficial effects for chronic, treatment-resistant depressed patients in terms of remission rates, rumination, quality of life, mindfulness skills, and self-compassion. Additionally, patients who completed MBCT showed significant reductions in depressive symptoms. Reasons for non-completion should be further investigated.
引用
收藏
页码:914 / 924
页数:11
相关论文
共 50 条
  • [1] A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
    Eisendrath, Stuart J.
    Gillung, Erin
    Delucchi, Kevin L.
    Segal, Zindel V.
    Nelson, J. Craig
    McInnes, L. Alison
    Mathalon, Daniel H.
    Feldman, Mitchell D.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (02) : 99 - 110
  • [2] Online mindfulness-based cognitive therapy for treatment-resistant depression: a parallel-arm randomized controlled feasibility trial
    Rodrigues, Michele Ferreira
    Quagliato, Laiana
    Appolinario, Jose Carlos
    Nardi, Antonio E.
    [J]. FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [3] Adapting Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
    Eisendrath, Stuart
    Chartier, Maggie
    McLane, Maura
    [J]. COGNITIVE AND BEHAVIORAL PRACTICE, 2011, 18 (03) : 362 - 370
  • [4] A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol
    Mira B. Cladder-Micus
    Janna N. Vrijsen
    Eni S. Becker
    Rogier Donders
    Jan Spijker
    Anne E. M. Speckens
    [J]. BMC Psychiatry, 15
  • [5] A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol
    Cladder-Micus, Mira B.
    Vrijsen, Janna N.
    Becker, Eni S.
    Donders, Rogier
    Spijker, Jan
    Speckens, Anne E. M.
    [J]. BMC PSYCHIATRY, 2015, 15
  • [6] Effects of Mindfulness-Based Cognitive Therapy on a Behavioural Measure of Rumination in Patients with Chronic, Treatment-Resistant Depression
    Mira B. Cladder-Micus
    Eni S. Becker
    Jan Spijker
    Anne E. M. Speckens
    Janna N. Vrijsen
    [J]. Cognitive Therapy and Research, 2019, 43 : 666 - 678
  • [7] Effects of Mindfulness-Based Cognitive Therapy on a Behavioural Measure of Rumination in Patients with Chronic, Treatment-Resistant Depression
    Cladder-Micus, Mira B.
    Becker, Eni S.
    Spijker, Jan
    Speckens, Anne E. M.
    Vrijsen, Janna N.
    [J]. COGNITIVE THERAPY AND RESEARCH, 2019, 43 (04) : 666 - 678
  • [8] Mindfulness-based cognitive therapy for treatment-resistant depression: A pilot study
    Eisendrath, Stuart J.
    Delucchi, Kevin
    Bitner, Robin
    Fenimore, Paul
    Smit, Martina
    McLane, Maura
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2008, 77 (05) : 319 - 320
  • [9] Mindfulness-Based Cognitive Therapy as a Treatment for Chronic Tinnitus: A Randomized Controlled Trial
    McKenna, Laurence
    Marks, Elizabeth M.
    Hallsworth, Christopher A.
    Schaette, Roland
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (06) : 351 - 361
  • [10] Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression
    Cladder-Micus, Mira B.
    Vrijsen, Janna N.
    Fest, Antine
    Spijker, Jan
    Donders, A. Rogier T.
    Becker, Eni S.
    Speckens, Anne E. M.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 335 : 410 - 417